annexin I



annexin I

M1MM1A2AA2M3MM3V4VV4S5SS5E6EE6F7FF7L8LL8K9KK9Q10QQ10A11AA11W12WW12F13FF13I14II14E15EE15N16NN16E17EE17E18EE18Q19QQ19E20EE20Y21YY21V22VV22Q23QQ23T24TT24V25VV25K26KK26S27SS27S28SS28K29KK29G30GG30G31GG31P32PP32G33GG33S34SS34A35AA35V36VV36S37SS37P38PP38Y39YY39P40PP40T41TT41F42FF42N43NN43P44PP44S45SS45S46SS46D47DD47... and 299 more residue(s)...... and 299 more residue(s)

SMILES None
InChIKey None
Sequence MAMVSEFLKQAWFIENEEQEYVQTVKSSKGGPGSAVSPYPTFNPSSDVAALHKAIMVKGVDEATIIDILTKRNNAQRQQIKAAYLQETGKPLDETLKKALTGHLEEVVLALLKTPAQFDADELRAAMKGLGTDEDTLIEILASRTNKEIRDINRVYREELKRDLAKDITSDTSGDFRNALLSLAKGDRSEDFGVNEDLADSDARALYEAGERRKGTDVNVFNTILTTRSYPQLRRVFQKYTKYSKHDMNKVLDLELKGDIEKCLTAIVKCATSKPAFFAEKLHQAMKGVGTRHKALIRIMVSRSEIDMNDIKAFYQKMYGISLCQAILDETKGDYEKILVALCGGN

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


Bioactivities

annexin I

M1MM1A2AA2M3MM3V4VV4S5SS5E6EE6F7FF7L8LL8K9KK9Q10QQ10A11AA11W12WW12F13FF13I14II14E15EE15N16NN16E17EE17E18EE18Q19QQ19E20EE20Y21YY21V22VV22Q23QQ23T24TT24V25VV25K26KK26S27SS27S28SS28K29KK29G30GG30G31GG31P32PP32G33GG33S34SS34A35AA35V36VV36S37SS37P38PP38Y39YY39P40PP40T41TT41F42FF42N43NN43P44PP44S45SS45S46SS46D47DD47... and 299 more residue(s)...... and 299 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.